Latest Financial Results News

WA Kaolin Limited has ramped up production with new classifiers, achieving record sales and securing a $7 million capital raise, while expanding its footprint in the Chinese market.

Beach Energy reported steady production and strong financials in Q3 FY25 despite flood disruptions in the Cooper Basin, with key projects advancing and liquidity improving.

Nickel Industries delivered a robust US$97.3 million Adjusted EBITDA in Q1 2025 despite production challenges and a declining nickel price. Key milestones include approval to nearly double Hengjaya Mine’s ore sales quota and a strategic deferral of substantial ENC acquisition payments.

ReadCloud reports robust first half FY25 results, driven by a standout 29% revenue increase in its VET-in-Schools segment, alongside positive cash flow and strengthened operating leverage.

Harmoney has raised its FY25 cash NPAT guidance to $5.5 million and announced an on-market share buy-back, setting the stage for accelerated loan book growth and improved returns in FY26.

Nuchev Limited reported a remarkable 215% increase in quarterly revenue, driven by the strategic launch of Oli6® in Vietnam and the acquisition of bWellness, signaling robust expansion across key Asia-Pacific markets.

Whitehaven Coal reported a solid Q3 FY25 with resilient production despite seasonal weather disruptions and a soft coal price environment, while bolstering its financial position through a significant Blackwater JV sell-down.

AKORA Resources has confirmed a robust Pre-Feasibility Study for its Bekisopa iron ore project in Madagascar, highlighting strong financial metrics and government support that pave the way for a 2Mtpa direct shipping ore operation.

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.

RMA Global Limited reported a robust Q3 FY25, achieving a 21% revenue increase to $5.5 million and marking its third consecutive quarter of positive operating cash flow, driven by US market expansion and the strategic acquisition of Curated Social.

Aroa Biosurgery reports a second consecutive quarter of positive operating cash flow and record sales for its Myriad product line, while maintaining full-year FY25 revenue and EBITDA guidance.

Algorae Pharmaceuticals reports significant progress in its AI-driven drug discovery platform, unveiling 24 novel oncology targets and appointing a seasoned Chief Commercial Officer to bolster market readiness.